Newfound Research’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$78K Buy
527
+49
+10% +$8.19K 0.19% 64
2022
Q2
$82K Buy
478
+108
+29% +$18.7K 0.17% 80
2022
Q1
$70K Buy
+370
New +$73.1K 0.09% 131
2021
Q4
Sell
-408
Closed -$79K 140
2021
Q3
$79K Sell
408
-84
-17% -$17K 0.13% 89
2021
Q2
$92K Buy
492
+14
+3% +$2.43K 0.18% 29
2021
Q1
$75K Sell
478
-243
-34% -$38.5K 0.17% 66
2020
Q4
$119K Buy
721
+517
+253% +$84.1K 0.31% 61
2020
Q3
$34K Buy
+204
New +$31.3K 0.1% 62

Other funds holding ZTS

Newfound Research's ZTS Position: Q3 2022 in Review

Newfound Research increased its Zoetis (ZTS) stake by 10% in Q3 2022, buying an estimated $8.19K and bringing the position to 527 shares worth $78K. The position accounts for 0.19% of the portfolio, ranked #64.

Newfound Research first reported a position in ZTS in Q3 2020 and has held it in 8 quarters since. The position peaked at $119K in Q4 2020. 1,508 funds tracked by Wall St. Rank hold ZTS as of Q3 2022.

  • Newfound Research held 527 shares of Zoetis worth $78K as of Q3 2022.
  • Newfound Research bought 49 Zoetis shares in Q3 2022, an estimated $8.19K.
  • Zoetis made up 0.19% of Newfound Research's portfolio in Q3 2022, its #64 holding.
  • Newfound Research first reported a position in Zoetis in Q3 2020 and has held it in 8 quarters since.
  • Newfound Research's Zoetis position peaked at $119K in Q4 2020.
  • 1,508 funds tracked by Wall St. Rank held Zoetis as of Q3 2022.

Based on Newfound Research's 13F filing for Q3 2022, filed 13 Oct 2022.